<DOC>
	<DOCNO>NCT00108576</DOCNO>
	<brief_summary>The purpose study : - To study efficacy divalproex treatment PTSD ; - To study plasma GABA ( gamma aminobutyric acid ) level treatment divalproex PTSD .</brief_summary>
	<brief_title>Divalproex Sodium Treatment PTSD ( Post-Traumatic Stress Disorder )</brief_title>
	<detailed_description>Objective : To study efficacy divalproex treatment PTSD . Research Design : This 8-week randomized , double-blind , placebo-controlled treatment trial divalproex . Methodology : After sign informed consent meeting inclusion/exclusion criterion , patient randomize either divalproex placebo 8-week duration . During study pharmacist maintains randomization log administers placebo divalproex ( 500 mg/capsule ) look-a-like tablet . Patients ' symptom , side effect compliance assess bi-weekly . Based symptomology occurrence side effect , investigator increase medication 500 mg ( one tablet ) increments every four day , tolerate , maximum therapeutic benefit achieve , exceed 3000 mg/day ( 6 capsule ) . The dosing twice daily , high dose bedtime . Compliance assess bi-weekly pill count blind valproic acid level week 4 week 8 . Patients give supportive clinical management clinic visit . An investigator available telephone 24 hr day case emergency . Patients may see often need . Efficacy measure follow assessment scale : MADRS ( Montgomery-Asberg Depression Rating Scale ) , Ham-A ( Hamilton Anxiety Scale ) , CGI-s ( Clinical Global Impressions-Severity Illness Scale ) , CGI-I ( Clinical Global Impressions-Improvement Scale ) , GAF ( Global Assessment Functioning ) , CAPS ( Clinician-Administered PTSD Scale ) , TOP-8 ( Treatment Outcome PTSD Rating Scale ) , DTS ( Davidson Trauma Scale ) . Results study use evaluate efficacy divalproex treatment PTSD . Significance : Divalproex show promise treat PTSD open label trial . This study next step prove divalproex 's efficacy treatment PTSD .</detailed_description>
	<mesh_term>Anticonvulsants</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<criteria>Diagnosis PTSD , confirm MINI ( MiniInternational Neuropsychiatric Interview ) CAPS Age 19 old No substance abuse/dependence previous 6 week ( except nicotine caffeine ) Free psychotropic medication 2 week ( except 6 week fluoxetine ) Clinically normal physical laboratory examination ( lab profile list ) . LFTs ( liver function test ) 2.5 time normal limit allow . Women childbearing potential must use medically approve method birth control ( condom , birth control pill , DepoProvera , diaphragm spermicides ) Signed informed consent Male female race ethnic origin Lifetime history bipolar I , psychotic , cognitive disorder Actively suicidal , homicidal , psychotic History sensitivity divalproex Unstable general medical condition Score 6 Question # 10 MADRS Women pregnant , plan become pregnant breastfeed study</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>anticonvulsant</keyword>
	<keyword>anxiety</keyword>
	<keyword>divalproex</keyword>
	<keyword>PTSD</keyword>
</DOC>